Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00706004 · ClinicalTrials.gov registry record · NA
Short Term Safety and Efficacy of Lubiprostone in Adults With Cystic Fibrosis
A NA study, sponsored by University of Arkansas.
- Completed
- Registry status
- NA
- Development phase
- 9
- Enrollment target
NCT00706004 is a NA study that has completed, run by University of Arkansas. The registered enrollment target is 9 participants.
The verdict
NCT00706004, a NA study, has completed, sponsored by University of Arkansas.
- COMPLETED
- Registry status
- NA
- Development phase
- 9 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the short term safety and effectiveness of lubiprostone when used for constipation in adults with cystic fibrosis.
Interventions
- DRUG lubiprostone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2008-07 |
| Est. Completion | 2009-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00706004
The ClinicalTrials.gov registry entry for NCT00706004 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Arkansas, which has 318 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which lubiprostone is the first listed.
NCT00706004 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00706004 about?
NCT00706004 is a clinical study titled "Short Term Safety and Efficacy of Lubiprostone in Adults With Cystic Fibrosis". The purpose of this study is to determine the short term safety and effectiveness of lubiprostone when used for constipation in adults with cystic fibrosis.
What is the current status of trial NCT00706004?
This trial is currently completed. It is a NA study. The enrollment target is 9 participants. The study started on 2008-07. Estimated completion is 2009-12.
What interventions are being tested in trial NCT00706004?
The interventions under investigation include: lubiprostone (DRUG).
Who is sponsoring clinical trial NCT00706004?
This trial is sponsored by University of Arkansas, which has 318 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.